3-iodobenzylguanidine has been researched along with Lewy Body Disease in 103 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 37 (35.92) | 29.6817 |
| 2010's | 49 (47.57) | 24.3611 |
| 2020's | 17 (16.50) | 2.80 |
| Authors | Studies |
|---|---|
| Adaniya, S; Koyama, K; Momose, T; Ogane, K; Takahashi, M | 1 |
| Donaghy, PC; Firbank, M; Kane, JPM; Lloyd, J; O'Brien, J; Petrides, GS; Roberts, G; Taylor, JP; Thomas, AJ | 1 |
| Bianconi, F; Marongiu, A; Nuvoli, S; Palumbo, B; Spanu, A | 1 |
| Blanc, F; Bousiges, O | 1 |
| Booij, J; Geibl, F; Habibi, M; Henrich, MT; Janzen, A; Librizzi, D; Luster, M; Mayer, G; Oertel, W; Sittig, E; Timmermann, L; Vadasz, D | 1 |
| Arafuka, S; Fujishiro, H; Iritani, S; Iwamoto, K; Miyata, S; Ogasawara, K; Ozaki, N; Torii, Y | 1 |
| An, YS; Chang, J; Kim, JY; Kim, MH; Kim, MS; Park, DG; Yoon, JH | 1 |
| Liu, W; Ou, X; Yao, X | 1 |
| Ito, K; Nihashi, T; Terasawa, T | 1 |
| Durcan, R; Howe, K; Kane, JPM; Lawley, S; Lloyd, JJ; O'Brien, JT; Petrides, GS; Roberts, G; Thomas, AJ | 1 |
| Komatsu, J; Nakajima, K; Okuda, K | 1 |
| Nakagawa, M; Ogasawara, K; Sakamoto, F; Shiraishi, S; Tomiguchi, S; Tsuda, N; Yamashita, Y | 1 |
| Fukatsu, R; Hara, Y; Takamaru, Y; Utsumi, K; Yamada, R; Yasumura, S | 1 |
| Calandra-Buonaura, G; Cason, E; Cortelli, P; Devigili, G; Donadio, V; Eleopra, R; Giannini, G; Giannoccaro, MP; Incensi, A; Liguori, R; Rizzo, G | 1 |
| Hashimoto, M; Ito, D; Iwabuchi, Y; Jinzaki, M; Kameyama, M; Matsusaka, Y; Narimatsu, H; Seki, M; Tabuchi, H; Yamada, Y | 1 |
| Fujishiro, H; Fukui, T; Hieda, S; Ito, T; Nagahama, Y; Ota, K; Suga, H; Yamagata, M | 1 |
| Ali, T; Allan, L; Barker, S; Barnett, N; Ciafone, J; Colloby, SJ; Donaghy, PC; Durcan, R; Firbank, MJ; Hamilton, CA; Howe, K; Lawley, S; Lloyd, J; O'Brien, J; Petrides, GS; Roberts, G; Taylor, JP; Thomas, AJ | 1 |
| Boccardi, M; Herholz, K; Nobili, F; Picco, A; Ratib, O; Sonni, I; Varrone, A | 1 |
| Abbasi, M; Afarideh, M; Aghamollaii, V; Ahmadi, M; Farzanefar, S; Ganji, M; Ghalandari, N; Loloee, S; Naseri, M; Tafakhori, A | 1 |
| Fujishiro, H; Iritani, S; Iwamoto, K; Miyata, S; Okuda, M; Ozaki, N; Torii, Y | 1 |
| Ishiura, H; Kurihara, M; Sasaki, T; Tsuji, S | 1 |
| Arai, H; Arai, T; Asada, T; Fujishiro, H; Hanyu, H; Iizuka, O; Iseki, E; Kashihara, K; Komatsu, J; Kosaka, K; Maruno, H; Mizukami, K; Mizuno, Y; Mori, E; Nakajima, K; Nakamura, H; Nakano, S; Nakashima, K; Nishio, Y; Orimo, S; Samuraki, M; Takahashi, A; Taki, J; Tokuda, T; Urakami, K; Utsumi, K; Wada, K; Washimi, Y; Yamada, M; Yamasaki, J; Yamashina, S; Yoshita, M | 1 |
| Acera, M; Concha, TP; Cortés, J; Del Pino, R; Fernández, M; Gabilondo, I; Gómez-Esteban, JC; Llorens, V; Murueta-Goyena, A; Rodriguez, T; Tijero, B | 1 |
| Esumi, S; Hayashi, S; Hinotsu, K; Oshima, E; Shinya, T; Takenoshita, S; Terada, S; Yamada, N; Yamaguchi, M | 1 |
| Bizimungu, A; Colson, C; Cytryn, E; Hambye, AS; Le Moine, M; Segers, K; Surquin, M | 1 |
| Fujii, Y; Ohi, M; Okura, M; Taniguchi, M; Uemori, H | 1 |
| Howe, K; Kane, JPM; Lloyd, JJ; O'Brien, JT; Petrides, GS; Roberts, G; Thomas, AJ | 1 |
| Hayashi, H; Horie, M; Mitsunami, K; Nakae, I | 1 |
| Ishii, K; Kawasaki, R; Oda, H; Ohkawa, S; Shimada, K; Terashima, A; Yamane, Y | 1 |
| Ballard, C; Grimmer, T | 1 |
| Hashimoto, M; Hirai, T; Ikeda, M; Namimoto, T; Sakamoto, F; Shiraishi, S; Tomiguchi, S; Uetani, H; Yamashita, Y; Yoshida, M | 1 |
| Ceriani, L; Giovanella, L; Treglia, G | 1 |
| Kaneko, K; Matsumura, H; Nakagome, K; Ohta, Y; Pu, S; Terachi, S; Yamada, T; Yamanashi, T; Yokoyama, K | 1 |
| Akiyama, N; Kobayashi, K; Maeda, T; Nakano, H; Yamamori, S | 1 |
| De Deyn, PP; Engelborghs, S; Goeman, J; Hauth, L; Martin, JJ; Slaets, S; Van Acker, F; Versijpt, J | 1 |
| Kihara, Y; Maeda, M; Morishita, J; Nishii, R; Sasaki, M; Shiiba, T; Tsuruta, K | 1 |
| Agostini, D; Bouvard, G; Defer, G; Lamotte, G; Lebasnier, A; Manrique, A; Peyronnet, D | 1 |
| Kumano, R; Maruyama, Y; Murakami, K; Yamada, T | 1 |
| Arai, H; Arai, T; Asada, T; Fujishiro, H; Hanyu, H; Iizuka, O; Iseki, E; Kashihara, K; Kosaka, K; Maruno, H; Mizukami, K; Mizuno, Y; Mori, E; Nakajima, K; Nakamura, H; Nakano, S; Nakashima, K; Nishio, Y; Orimo, S; Samuraki, M; Takahashi, A; Taki, J; Tokuda, T; Urakami, K; Utsumi, K; Wada, K; Washimi, Y; Yamada, M; Yamasaki, J; Yamashina, S; Yoshita, M | 1 |
| Agostini, D; Defer, GL; Lamotte, G; Lebasnier, A; Morello, R | 1 |
| Kim, JS; Lee, KS; Oh, YS; Park, HE; Park, JW; Song, IU; Yang, DW | 1 |
| Fukasawa, R; Hanyu, H; Hatanaka, H; Hirao, K; Hirose, D; Kanetaka, H; Namioka, N; Sakurai, H; Shimizu, S; Umahara, T | 1 |
| Baba, T; Iizuka, O; Matsuda, M; Mori, E; Narita, W; Nishio, Y; Odagiri, H | 1 |
| Arai, T; Asada, T; Darby, D; Hattori, S; Kikuchi, N; Mizukami, K; Ogawa, R; Takahashi, S | 1 |
| Aoki, M; Baba, T; Hasegawa, T; Iizuka, O; Inoue, K; Kikuchi, A; Matsuda, M; Mori, E; Nishio, Y; Odagiri, H; Takeda, A; Taki, Y | 1 |
| Fujishiro, H; Kosaka, K; Ozaki, N; Ukai, K; Watanabe, M | 1 |
| Antelmi, L; Biffi, AM; Calcagni, ML; Capitanio, S; Cecchin, D; Corso, A; Gabanelli, SV; Guerra, UP; Merello, M; Micheli, A; Muscio, C; Nobili, F; Piccardo, A; Pinto, P; Riva, R; Sacco, L; Stefanini, S; Tettamanti, M; Tiraboschi, P; Vai, P; Vidale, S; Volterrani, D | 1 |
| Hashimoto, E; Hatakeyama, S; Ishii, T; Iwamoto, T; Kawanishi, C; Kawasaki, K; Kobayashi, S; Makino, K; Mikuni, K; Murayama, T; Tateno, M; Tsujino, H; Ukai, W; Utsumi, K | 1 |
| Inui, Y; Kosaka, K; Manabe, Y; Toyama, H | 1 |
| Camacho, V; Carrio, I; Estorch, M; Flotats, A; Kulisevsky, J; Paredes, P; Rivera, E; Rodríguez-Revuelto, A | 1 |
| Hirata, K; Iwanami, M; Miyamoto, M; Miyamoto, T; Nishibayashi, M; Suzuki, K | 1 |
| Furukawa, Y; Kobayashi, S; Shirasaka, T; Tateno, M; Utumi, K | 1 |
| Arita, H; Fujita, S; Futami, S; Kawai, K; Kiyohara, S; Nagamachi, S; Nakazato, M; Nishii, R; Tamura, S; Wakamatsu, H; Yamashita, S | 1 |
| Fujii, K; Furukawa, Y; Kobayashi, S; Morii, H; Saito, T; Shirasaka, T; Tateno, M; Utsumi, K; Yasumura, S | 1 |
| Matsuda, H; Mizumura, S; Waragai, M; Yamada, T | 1 |
| Kinuya, S; Matsuo, S; Nakajima, K; Taki, J; Yoshita, M | 1 |
| Mahowald, MW; Schenck, CH | 1 |
| Arabia, G; Bagnato, A; Cascini, GL; Chiriaco, C; Cipullo, S; Condino, F; De Marco, EV; Manna, I; Morelli, M; Morgante, L; Nicoletti, G; Novellino, F; Paglionico, S; Pugliese, P; Quattrone, A; Salsone, M; Zappia, M | 1 |
| Orimo, S | 3 |
| Cabello-García, D; Carnero-Pardo, C; Escamilla-Sevilla, F; Gallego-Peinado, M; Gómez Río, M; Mínguez-Castellanos, A; Muñoz-Pasadas, M; Ortega-Léon, T; Ortega-Moreno, A; Pérez-Navarro, MJ; Rebollo-Aguirre, AC | 1 |
| Aonuma, K; Asada, T; Homma, T; Kinoshita, T; Kosaka, K; Mizukami, K | 1 |
| Akiyama, N; Kobayashi, K; Koshino, Y; Nakano, H; Sumiya, H; Urata, K | 1 |
| Kobayashi, S; Morii, H; Saito, T; Tateno, M; Utsumi, K | 1 |
| Rascol, O; Schelosky, L | 1 |
| Endo, T; Hirokawa, K; Ichihara, K; Kitagawa, M; Kobayashi, T; Kurata, M; Takahashi, M; Toru, S; Uchihara, T | 1 |
| Arai, H; Fujishiro, H; Higashi, S; Iseki, E; Kasanuki, K; Murayama, N; Sato, K; Suzuki, M; Yamamoto, R | 1 |
| Alcolea Rodríguez, D; Blesa González, R; Camacho Martí, V; Da Silva Alves, L; Estorch Cabrera, M; Gómez-Isla, T; Lleó Bisa, A; Marquié Sayagués, M; Molina-Porcel, L; Sala Matavera, I; Sánchez-Saudinós, MB | 1 |
| Alvés, L; Artigas, C; Blesa, R; Camacho, V; Carrió, I; Duch, J; Estorch, M; Flotats, A; Gómez-Isla, T; Lleó, A; Marquié, M | 1 |
| Haruta, H; Kishi, M; Ogata, T; Ogawa, E; Sakakibara, R; Tateno, F; Terada, H | 1 |
| King, AE; Mintz, J; Royall, DR | 1 |
| Kondo, C; Kusakabe, K; Momose, M; Uchiyama, S; Uchiyama, Y | 1 |
| Bagnato, A; Di Giuda, D; Giordano, A; Treglia, G | 1 |
| Cason, E; Cocciolillo, F; Di Giuda, D; Fagioli, G; Giordano, A; Stefanelli, A; Treglia, G | 1 |
| Maeda, K; Sakai, K; Yamane, Y | 1 |
| Kinuya, S; Matsuo, S; Nakajima, K; Okuda, K; Taki, J; Yamada, M; Yoshita, M | 1 |
| Fujishiro, H; Iseki, E; Kitazawa, M; Nakamura, S; Sato, K | 1 |
| Fujishiro, H; Iseki, E; Kasanuki, K; Murayama, N; Ota, K; Sato, K; Suzuki, M | 1 |
| Artigas, C; Camacho, V; Carrió, I; Deportos, J; Domènech, A; Duch, J; Estorch, M; Fernández, A; Flotats, A; Geraldo, LL; Lleó, A; Marquié, M | 1 |
| Kitagawa, Y | 1 |
| Fujino, S; Higashi, K; Hirose, G; Hori, A; Kaito, M; Kakeshita, K; Kataoka, S; Miaki, M; Saiki, M; Saiki, S; Sakai, K; Taki, S | 1 |
| Aida, J; Hirokawa, K; Ito, Y; Ohkawa, S; Okada, Y; Yasuhara, M | 1 |
| Taki, J; Tonami, N; Yamada, M; Yoshita, M | 1 |
| Amino, T; Itoh, Y; Kojo, T; Mori, F; Orimo, S; Takahashi, A; Takahashi, H; Tsuchiya, K; Uchihara, T; Wakabayashi, K | 1 |
| Abo, M; Fukumitsu, N; Hashimoto, M; Inoue, K; Ito, Y; Kurita, A; Suzuki, M; Urashima, M | 1 |
| Estorch, M | 1 |
| Abe, K; Chikamori, T; Hanyu, H; Hirao, K; Iwamoto, T; Kanetaka, H; Koizumi, K; Shimizu, S; Usui, Y; Yamashina, A | 1 |
| Matsumoto, Y; Nakajima, K; Noguchi-Shinohara, M; Taki, J; Yamada, M; Yokoyama, K; Yoshita, M | 1 |
| Kashihara, K; Kawada, S; Ohno, M; Okumura, Y | 1 |
| Abe, K; Chikamori, T; Hanyu, H; Hida, S; Hirao, K; Iwamoto, T; Koizumi, K; Sakurai, H; Shimizu, S; Yamashina, A | 1 |
| Hanyu, H; Hirao, K; Iwamoto, T; Kanetaka, H; Sakurai, H; Shimizu, S | 1 |
| Inoue, K; Mochio, S; Morita, M; Oka, H; Onouchi, K; Yoshioka, M | 1 |
| Kitayama, M; Nakashima, K; Nakaso, K; Wada-Isoe, K | 1 |
| Irizawa, Y; Kitayama, M; Nakashima, K; Wada-Isoe, K | 1 |
| Imamura, K; Kitamaya, M; Kowa, H; Nakashima, K; Wada-Isoe, K | 1 |
| Inui, Y; Iwata, N; Katada, K; Kosaka, K; Manabe, Y; Sarai, M; Sato, T; Toyama, H | 1 |
| Hirai, T; Inoue, K; Ito, Y; Mochio, S; Morita, M; Oka, H; Onouchi, K; Suzuki, M; Yoshioka, M | 1 |
| Fukuyama, H; Kawanishi, T; Mitake, S; Oguri, T; Tachibana, N | 1 |
| Hamamoto, M; Katayama, Y; Mori, O; Nagayama, H; Nishiyama, Y; Ueda, M; Yamazaki, M | 1 |
| Azevedo, JC; Barbirato, GB; Boechat, Y; Cabral, H; Correa, PL; Dohmann, HF; Felix, RM; Manhães, AC; Mendes, MH; Mesquita, CT; Schmidt, GJ; Schmidt, SL; Tolentino, JC | 1 |
| Aiba, I; Doyu, M; Hirayama, M; Ieda, T; Katayama, T; Sobue, G; Takeda, A; Watanabe, H | 1 |
| Taki, J; Yamada, M; Yoshita, M | 1 |
12 review(s) available for 3-iodobenzylguanidine and Lewy Body Disease
| Article | Year |
|---|---|
Biomarkers of Dementia with Lewy Bodies: Differential Diagnostic with Alzheimer's Disease.
Topics: 3-Iodobenzylguanidine; Alzheimer Disease; Biomarkers; Diagnosis, Differential; Humans; Lewy Body Disease; Neurodegenerative Diseases; Tomography, Emission-Computed, Single-Photon | 2022 |
[The clinical value of
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Lewy Bodies; Lewy Body Disease | 2023 |
Diagnostic accuracy of DAT-SPECT and MIBG scintigraphy for dementia with Lewy bodies: an updated systematic review and Bayesian latent class model meta-analysis.
Topics: 3-Iodobenzylguanidine; Bayes Theorem; Humans; Latent Class Analysis; Lewy Body Disease; Radionuclide Imaging; Tomography, Emission-Computed, Single-Photon | 2020 |
Clinical validity of presynaptic dopaminergic imaging with
Topics: 3-Iodobenzylguanidine; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Diagnosis, Differential; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Nortropanes; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon | 2017 |
Current role and future perspectives of radioiodinated MIBG in the evaluation of dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Biological Transport; Dementia; Diagnosis, Differential; Dopamine; Humans; Iodine Radioisotopes; Lewy Body Disease; Radionuclide Imaging; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2014 |
Iodine-123-MIBG sympathetic imaging in Lewy-body diseases and related movement disorders.
Topics: 3-Iodobenzylguanidine; Alzheimer Disease; Diagnosis, Differential; Humans; Lewy Body Disease; Parkinson Disease; Radionuclide Imaging; Sympathetic Nervous System | 2008 |
[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Topics: 3-Iodobenzylguanidine; alpha-Synuclein; Biomarkers; Diagnosis, Differential; Early Diagnosis; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Nerve Degeneration; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2008 |
123I-metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders.
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Heart; Humans; Lewy Body Disease; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals | 2009 |
Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.
Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; Humans; Lewy Body Disease; Myocardial Perfusion Imaging; Radionuclide Imaging; Radiopharmaceuticals | 2011 |
MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis.
Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; False Negative Reactions; False Positive Reactions; Heart; Humans; Lewy Body Disease; Parkinson Disease; Parkinsonian Disorders; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; ROC Curve | 2012 |
Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease.
Topics: 3-Iodobenzylguanidine; Animals; Autonomic Nervous System; Brain; Clinical Trials as Topic; Humans; Lewy Body Disease; Neurodegenerative Diseases; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals | 2004 |
[Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Topics: 3-Iodobenzylguanidine; alpha-Synuclein; Diagnosis, Differential; Early Diagnosis; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Myocardium; Nerve Degeneration; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 2008 |
2 trial(s) available for 3-iodobenzylguanidine and Lewy Body Disease
| Article | Year |
|---|---|
On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Female; Heart Diseases; Humans; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Tomography, X-Ray Computed | 2016 |
Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Confounding Factors, Epidemiologic; Diagnosis, Differential; Female; Humans; Japan; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Prevalence; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
89 other study(ies) available for 3-iodobenzylguanidine and Lewy Body Disease
| Article | Year |
|---|---|
Influence of antidepressant use on
Topics: 3-Iodobenzylguanidine; Antidepressive Agents; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Lung; Radiopharmaceuticals; Retrospective Studies | 2022 |
Can early phase cardiac [123I]mIBG images be used to diagnose Lewy body disease?
Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Radiopharmaceuticals | 2022 |
123I-MIBG Cardiac Scintigraphy and Heart/Mediastinum Ratio in Neurodegenerative Disorders: Is Delayed Scan Really Necessary?
Topics: 3-Iodobenzylguanidine; Heart; Humans; Lewy Body Disease; Mediastinum; Neurodegenerative Diseases; Radionuclide Imaging; Radiopharmaceuticals | 2022 |
Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder.
Topics: 3-Iodobenzylguanidine; Humans; Lewy Body Disease; Olfaction Disorders; Parkinson Disease; REM Sleep Behavior Disorder; Sympathectomy; Tomography, Emission-Computed, Single-Photon; Tropanes | 2022 |
Temporal trajectories of proposed biomarkers in psychiatric-onset prodromal dementia with Lewy bodies: a case report.
Topics: 3-Iodobenzylguanidine; Biomarkers; Humans; Lewy Bodies; Lewy Body Disease; Prodromal Symptoms | 2023 |
Neurofilament light chain and cardiac MIBG uptake as predictors for phenoconversion in isolated REM sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Humans; Intermediate Filaments; Lewy Body Disease; Multiple System Atrophy; Parkinson Disease; REM Sleep Behavior Disorder | 2023 |
Cardiac
Topics: 3-Iodobenzylguanidine; Adult; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Case-Control Studies; Cohort Studies; Female; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Radiopharmaceuticals | 2021 |
What does diagnostic threshold mean? Deterministic and probabilistic considerations.
Topics: 3-Iodobenzylguanidine; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Humans; Iodine Radioisotopes; Lewy Body Disease; Middle Aged; Probability; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
A diagnostic strategy for Lewy body disease using DAT-SPECT, MIBG and Combined index.
Topics: 3-Iodobenzylguanidine; Aged; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Lewy Body Disease; Male; Myocardial Perfusion Imaging; ROC Curve; Tomography, Emission-Computed, Single-Photon | 2020 |
Characteristics of initial symptoms and symptoms at diagnosis in probable dementia with Lewy body disease: incidence of symptoms and gender differences.
Topics: 3-Iodobenzylguanidine; Female; Humans; Incidence; Lewy Body Disease; Male; Retrospective Studies; Sex Characteristics | 2020 |
Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
Topics: 3-Iodobenzylguanidine; Aged; alpha-Synuclein; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Myocardium; Parkinson Disease; Peripheral Nerves; Phosphorylation; Pure Autonomic Failure; Radionuclide Imaging; Radiopharmaceuticals; Skin | 2020 |
A diagnostic strategy for Parkinsonian syndromes using quantitative indices of DAT SPECT and MIBG scintigraphy: an investigation using the classification and regression tree analysis.
Topics: 3-Iodobenzylguanidine; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Humans; Lewy Body Disease; Parkinsonian Disorders; Radionuclide Imaging; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2021 |
Early diagnosis of prodromal dementia with Lewy bodies using clinical history of probable REM sleep behaviour disorder and cardiac
Topics: 3-Iodobenzylguanidine; Early Diagnosis; Female; Humans; Lewy Body Disease; Male; Radionuclide Imaging; REM Sleep Behavior Disorder | 2021 |
Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Diagnosis, Differential; Female; Follow-Up Studies; Heart; Humans; Lewy Body Disease; Male; Myocardial Perfusion Imaging; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tropanes | 2021 |
Potential diagnostic value of
Topics: 3-Iodobenzylguanidine; Adolescent; Alzheimer Disease; Dementia; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Myocardial Perfusion Imaging; ROC Curve | 2017 |
Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [
Topics: 3-Iodobenzylguanidine; Age of Onset; Aged; Aged, 80 and over; Dopamine Plasma Membrane Transport Proteins; Early Diagnosis; Electroencephalography; Electromyography; Female; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Polysomnography; Radiopharmaceuticals; REM Sleep Behavior Disorder; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2018 |
HIV Dementia with a Decreased Cardiac
Topics: 3-Iodobenzylguanidine; AIDS Dementia Complex; Anti-Retroviral Agents; Biomarkers; Cognitive Dysfunction; Fatal Outcome; HIV Infections; Humans; Lewy Bodies; Lewy Body Disease; Male; Middle Aged; Radiopharmaceuticals; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2018 |
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Cross-Sectional Studies; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Lewy Body Disease; Male; Myocardial Perfusion Imaging; Sensitivity and Specificity | 2018 |
Myocardial MIBG scintigraphy in genetic Parkinson's disease as a model for Lewy body disorders.
Topics: 3-Iodobenzylguanidine; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Phenotype; Radionuclide Imaging; Retrospective Studies | 2019 |
Clinical characteristics of elderly depressive patients with low metaiodobenzylguanidine uptake.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Depression; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Radionuclide Imaging; Radiopharmaceuticals | 2019 |
Myocardial metaiodobenzylguanidine tomoscintigraphy for the diagnosis of Lewy body disease in patients with high clinical suspicion and non-diagnostic ioflupane single-photon emission computed tomography.
Topics: 3-Iodobenzylguanidine; Humans; Lewy Body Disease; Myocardial Perfusion Imaging; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2019 |
[A case of severe obstructive sleep apnea mimicking REM sleep behavior disorder].
Topics: 3-Iodobenzylguanidine; alpha-Synuclein; Diagnosis, Differential; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Polysomnography; Radiopharmaceuticals; REM Sleep Behavior Disorder; Severity of Illness Index; Sleep Apnea, Obstructive; Video Recording | 2019 |
A comparison of visual and semiquantitative analysis methods for planar cardiac 123I-MIBG scintigraphy in dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Heart; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Radionuclide Imaging; ROC Curve; Time Factors | 2019 |
Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson's and heart diseases.
Topics: 3-Iodobenzylguanidine; Aged; Biological Transport; Diagnosis, Differential; Female; Heart Diseases; Humans; Lewy Body Disease; Lung; Male; Middle Aged; Parkinson Disease; Prognosis; Radionuclide Imaging; Survival Analysis; Ventricular Dysfunction, Left | 2013 |
Myocardial scintigraphy may predict the conversion to probable dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Cognition Disorders; Female; Humans; Inosine Monophosphate; Lewy Body Disease; Magnetic Resonance Imaging; Male; Mental Status Schedule; Myocardial Perfusion Imaging; Neuropsychological Tests; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Statistics, Nonparametric; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2013 |
Improving diagnosis of possible DLB: is there a role for MIBG myocardial scintigraphy?
Topics: 3-Iodobenzylguanidine; Humans; Lewy Body Disease; Myocardial Perfusion Imaging; Radiopharmaceuticals | 2013 |
Diagnosis of dementia with Lewy bodies: diagnostic performance of combined ¹²³I-IMP brain perfusion SPECT and ¹²³I-MIBG myocardial scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Area Under Curve; Brain; Female; Humans; Iofetamine; Lewy Body Disease; Male; Middle Aged; Multimodal Imaging; Myocardial Perfusion Imaging; Retrospective Studies; Tomography, Emission-Computed, Single-Photon | 2014 |
Milnacipran influences the indexes of I-metaiodobenzylguanidine scintigraphy in elderly depressed patients.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Antidepressive Agents; Brain; Cyclopropanes; Depressive Disorder, Major; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Milnacipran; Radionuclide Imaging; Radiopharmaceuticals | 2014 |
Pure psychiatric presentation of the Lewy body disease is depression--an analysis of 60 cases verified with myocardial meta-iodobenzylguanidine study.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Biomarkers; Depressive Disorder; Female; Hallucinations; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardium; Parkinson Disease; Psychotic Disorders; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2015 |
Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2015 |
Assessment of the efficacy of early phase parameters by (123)I-MIBG dynamic imaging for distinguishing Lewy body-related diseases from Parkinson's syndrome.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Middle Aged; Radionuclide Imaging; Retrospective Studies; Time Factors | 2015 |
Potential diagnostic value of regional myocardial adrenergic imaging using (123)I-MIBG SPECT to identify patients with Lewy body diseases.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2015 |
Comparison of the diagnostic performance of H/M ratio between early and delayed phases for Lewy body disease.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Female; Heart; Humans; Lewy Body Disease; Male; Mediastinum; Middle Aged; Radionuclide Imaging; Retrospective Studies; ROC Curve; Time Factors | 2015 |
Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Lewy Bodies; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Reproducibility of Results; ROC Curve; Sensitivity and Specificity | 2015 |
Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses.
Topics: 3-Iodobenzylguanidine; Aged; Brain; Female; Heart; Humans; Lewy Body Disease; Male; Mediastinum; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2015 |
(123)I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer's disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Female; Humans; Hypotension, Orthostatic; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Radionuclide Imaging; Radiopharmaceuticals | 2015 |
Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
Topics: 3-Iodobenzylguanidine; Aged, 80 and over; Alzheimer Disease; Diagnosis, Differential; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Lewy Body Disease; Male; Multimodal Imaging; Myocardial Perfusion Imaging; Tomography, Emission-Computed, Single-Photon | 2016 |
Clinical characteristics of idiopathic normal pressure hydrocephalus with Lewy body diseases.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Enzyme Inhibitors; Female; Humans; Hydrocephalus, Normal Pressure; Iodine Isotopes; Lewy Body Disease; Male; Myocardial Perfusion Imaging; Retrospective Studies | 2015 |
Ventilatory Response to Hypercapnia Predicts Dementia with Lewy Bodies in Late-Onset Major Depressive Disorder.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Depressive Disorder, Major; Follow-Up Studies; Heart Rate; Humans; Hypercapnia; Hypotension, Orthostatic; Kaplan-Meier Estimate; Lewy Body Disease; Middle Aged; Partial Pressure; Psychiatric Status Rating Scales; Retrospective Studies; Ventilators, Mechanical | 2016 |
Similarity of symptoms between transient epileptic amnesia and Lewy body disease.
Topics: 3-Iodobenzylguanidine; Aged; Amnesia; Anticonvulsants; Cognition Disorders; Electroencephalography; Female; Hallucinations; Humans; Levetiracetam; Lewy Body Disease; Myocardial Perfusion Imaging; Parkinsonian Disorders; Piracetam; Seizures; Tomography, Emission-Computed, Single-Photon | 2017 |
(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Corpus Striatum; Diagnosis, Differential; Female; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tropanes | 2016 |
The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Brain; Cerebrovascular Circulation; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Lewy Body Disease; Male; Myocardial Perfusion Imaging; Perfusion Imaging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2017 |
123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Cardiac (123)I-metaiodobenzylguanidine imaging allows early identification of dementia with Lewy bodies during life.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Cognition Disorders; Diagnosis, Differential; Early Diagnosis; Female; Follow-Up Studies; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Neurodegenerative Diseases; Reproducibility of Results; Time Factors | 2008 |
123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorder.
Topics: 3-Iodobenzylguanidine; Aged; Cross-Sectional Studies; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Mediastinum; Middle Aged; Multiple System Atrophy; Neurodegenerative Diseases; Parkinson Disease; Polysomnography; Radionuclide Imaging; REM Sleep Behavior Disorder; Supranuclear Palsy, Progressive | 2008 |
[Improved diagnosis of dementia with Lewy bodies by the combination of 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy and 99mTc-ethylcysteinate dimmer (ECD) brain perfusion SPECT].
Topics: 3-Iodobenzylguanidine; Brain; Cerebrovascular Circulation; Cysteine; Female; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Organotechnetium Compounds; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2008 |
Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Cerebrovascular Circulation; Cross-Sectional Studies; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Occipital Lobe; Parkinson Disease; Parkinson Disease, Secondary; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 2008 |
Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cysteine; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Occipital Lobe; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2008 |
Differentiation of early-stage Alzheimer's disease from other types of dementia using brain perfusion single photon emission computed tomography with easy Z-score imaging system analysis.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cysteine; Dementia; Dementia, Vascular; Diagnosis, Differential; Disease Progression; Female; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Middle Aged; Neuropsychological Tests; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2008 |
Subclinical REM sleep behavior disorder and its clinical and research implications.
Topics: 3-Iodobenzylguanidine; Aged; Dopamine Plasma Membrane Transport Proteins; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Polysomnography; Radionuclide Imaging; REM Sleep Behavior Disorder; Risk Factors | 2008 |
Myocardial (123)I-MIBG scintigraphy for differentiation of Lewy bodies disease from FTD.
Topics: 3-Iodobenzylguanidine; Aged; Analysis of Variance; Female; Frontotemporal Dementia; Heart; Humans; Lewy Body Disease; Male; Mediastinum; Middle Aged; Myocardial Perfusion Imaging; Neuropsychological Tests; Radiopharmaceuticals; Statistics, Nonparametric; Sympathetic Nervous System | 2010 |
[Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders].
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Sympathectomy | 2009 |
Decreased ventilatory response to hypercapnia in dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Female; Heart; Heart Rate; Humans; Hypercapnia; Hypotension, Orthostatic; Lewy Body Disease; Male; Myocardial Perfusion Imaging; Neuropsychological Tests; Partial Pressure; Tidal Volume; Ventilation | 2009 |
Detection of Lewy body disease in patients with late-onset depression, anxiety and psychotic disorder with myocardial meta-iodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Age of Onset; Aged; Aged, 80 and over; Anxiety Disorders; Cognition Disorders; Depressive Disorder; Female; Hallucinations; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Psychotic Disorders; Radiopharmaceuticals | 2010 |
Decreased cardiac MIBG uptake, its correlation with clinical symptoms in dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Heart; Humans; Lewy Body Disease; Male; Radionuclide Imaging; Radiopharmaceuticals | 2009 |
Depletion or preservation of cardiac sympathetic nerve - an autopsy-verified contrast in two cases of Alzheimer's disease with or without Lewy bodies.
Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Aged; Aged, 80 and over; Alzheimer Disease; Autopsy; Female; Hippocampus; Humans; Lewy Bodies; Lewy Body Disease; Male; Myocardium; Neurofilament Proteins; Radiopharmaceuticals; tau Proteins; Tyrosine 3-Monooxygenase | 2010 |
Diffuse occipital hypometabolism on [18 F]-FDG PET scans in patients with idiopathic REM sleep behavior disorder: prodromal dementia with Lewy bodies?
Topics: 3-Iodobenzylguanidine; Aged; Dominance, Cerebral; Early Diagnosis; Energy Metabolism; Female; Fluorodeoxyglucose F18; Frontal Lobe; Gyrus Cinguli; Heart; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Iodine Radioisotopes; Lewy Body Disease; Male; Neuropsychological Tests; Occipital Lobe; Positron-Emission Tomography; Radionuclide Imaging; REM Sleep Behavior Disorder; Statistics as Topic; Sympathetic Nervous System; Temporal Lobe | 2010 |
[(123)I-MIBG myocardial scintigraphy in the diagnosis of Lewy body dementia].
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Myocardial Perfusion Imaging; Radiopharmaceuticals | 2010 |
Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Basal Ganglia; Female; Heart Diseases; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Striatonigral Degeneration; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon; Tropanes | 2011 |
Sensitivity and specificity of metaiodobenzylguanidine (MIBG) myocardial accumulation in the diagnosis of Lewy body diseases in a movement disorder clinic.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Humans; Lewy Body Disease; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2011 |
Comparison of parameters of (123)I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features.
Topics: 3-Iodobenzylguanidine; Aged; Analysis of Variance; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Mediastinum; Myocardium; Parkinsonian Disorders; Radionuclide Imaging; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2011 |
¹²³I-MIBG cardiac scintigraphy in Lewy body-related disorders.
Topics: 3-Iodobenzylguanidine; Humans; Lewy Body Disease; Radionuclide Imaging; Radiopharmaceuticals | 2011 |
Dementia with Lewy bodies is associated with higher scores on the Geriatric Depression Scale than is Alzheimer's disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Comorbidity; Depressive Disorder; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Mental Status Schedule; Personality Inventory; Psychometrics; Radiopharmaceuticals; Retrospective Studies; Statistics as Topic; Tomography, Emission-Computed, Single-Photon | 2011 |
Standardization of metaiodobenzylguanidine heart to mediastinum ratio using a calibration phantom: effects of correction on normal databases and a multicentre study.
Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Calibration; Databases, Factual; Diagnosis, Differential; Humans; Lewy Body Disease; Mediastinum; Myocardium; Phantoms, Imaging; Reference Standards; Retrospective Studies; Societies, Scientific; Tomography, Emission-Computed, Single-Photon | 2012 |
Early detection of dementia with Lewy bodies in patients with amnestic mild cognitive impairment using 123I-MIBG cardiac scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Amnesia; Cognitive Dysfunction; Female; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging | 2012 |
Glucose hypometabolism in primary visual cortex is commonly associated with clinical features of dementia with Lewy bodies regardless of cognitive conditions.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Visual Cortex | 2012 |
[MIBG myocardial scintigraphy].
Topics: 3-Iodobenzylguanidine; Dementia; Diagnosis, Differential; Frontotemporal Dementia; Heart; Humans; Lewy Body Disease; Radionuclide Imaging | 2011 |
[Utility of early imaging of myocardial innervation scintigraphy in the diagnosis of Lewy Body Dementia].
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Imaging Techniques; Cognition Disorders; Diagnosis, Differential; Female; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Neurodegenerative Diseases; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Time Factors | 2013 |
Usefulness of [123I] MIBG myocardial scintigraphy for differential diagnosis of Alzheimer's disease and dementia with lewy bodies.
Topics: 3-Iodobenzylguanidine; Alzheimer Disease; Diagnosis, Differential; Heart; Humans; Lewy Body Disease; Radionuclide Imaging; Radiopharmaceuticals | 2003 |
Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
Topics: 3-Iodobenzylguanidine; Adult; Age of Onset; Aged; Aged, 80 and over; Analysis of Variance; Case-Control Studies; Enzyme Inhibitors; Female; Gait Ataxia; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Multiple System Atrophy; Neurologic Examination; Parkinson Disease; Phenotype; Radionuclide Imaging; Regression Analysis; Severity of Illness Index; Statistics, Nonparametric; Tremor | 2004 |
Lewy bodies in the sinoatrial nodal ganglion: clinicopathological studies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Atrial Fibrillation; Female; Ganglia, Autonomic; Heart; Humans; Lewy Bodies; Lewy Body Disease; Male; Parkinson Disease; Radionuclide Imaging; Sinoatrial Node | 2004 |
Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Ganglia, Sympathetic; Heart; Humans; Immunohistochemistry; Lewy Body Disease; Male; Middle Aged; Myocardium; Neurodegenerative Diseases; Neurons; Tyrosine 3-Monooxygenase | 2005 |
Impaired myocardial 123I-metaiodobenzylguanidine uptake in Lewy body disease: comparison between dementia with Lewy bodies and Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Demography; Female; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies | 2006 |
From the heart to the brain via cardiac MIBG imaging.
Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Brain; Clinical Trials as Topic; Diagnosis, Differential; Heart; Humans; Lewy Body Disease; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2006 |
Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Brain; Diagnosis, Differential; Humans; Iofetamine; Lewy Body Disease; Perfusion; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2006 |
Reduced cardiac uptake and enhanced washout of 123I-MIBG in pure autonomic failure occurs conjointly with Parkinson's disease and dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Dementia; Female; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Myocardium; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals | 2006 |
The role of 123I-metaiodobenzylguanidine myocardial scintigraphy in the diagnosis of Lewy body disease in patients with dementia in a memory clinic.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Brain; Dementia; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Memory Disorders; Myocardium; Nerve Degeneration; Neuropsychological Tests; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed | 2006 |
Phenylephrine and pilocarpine eye drop test for dementia with Lewy bodies and Alzheimer's disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Iris; Lewy Body Disease; Male; Miosis; Miotics; Mydriasis; Mydriatics; Ophthalmic Solutions; Phenylephrine; Pilocarpine; Predictive Value of Tests; Pupil | 2007 |
Cardiovascular autonomic dysfunction in dementia with Lewy bodies and Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Arteries; Autonomic Nervous System Diseases; Baroreflex; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Female; Heart; Humans; Hypotension, Orthostatic; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Norepinephrine; Parkinson Disease; Radionuclide Imaging; Reflex, Abnormal; Sympathetic Fibers, Postganglionic | 2007 |
Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Humans; Lewy Body Disease; Middle Aged; Peptide Fragments; Phosphorylation; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; tau Proteins | 2007 |
Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Age Factors; Age of Onset; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Autonomic Nervous System Diseases; Comorbidity; Down-Regulation; Female; Hallucinations; Heart; Heart Conduction System; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Multivariate Analysis; Parkinson Disease; Predictive Value of Tests; Radionuclide Imaging; Sympathetic Fibers, Postganglionic | 2008 |
Serum heart-fatty acid binding protein levels in patients with Lewy body disease.
Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Area Under Curve; Biomarkers; Diagnosis, Differential; Dopamine Agonists; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Heart; Humans; Lewy Body Disease; Male; Mediastinum; Parkinson Disease; Radiopharmaceuticals; ROC Curve; Tomography, Emission-Computed, Single-Photon | 2008 |
Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Brain; Female; Heart; Humans; Imaging, Three-Dimensional; Iofetamine; Lewy Body Disease; Male; Perfusion; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2007 |
Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in Lewy body disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Blood Pressure; Cardiac Output; Female; Heart; Heart Rate; Humans; Lewy Body Disease; Male; Middle Aged; Myocardium; Predictive Value of Tests; Radionuclide Imaging; Sympathetic Fibers, Postganglionic; Valsalva Maneuver | 2007 |
Decrease in myocardial 123I-MIBG radioactivity in REM sleep behavior disorder: two patients with different clinical progression.
Topics: 3-Iodobenzylguanidine; Age of Onset; Aged; Disease Progression; Electrocardiography; Follow-Up Studies; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardium; Parkinson Disease; Polysomnography; Radionuclide Imaging; REM Sleep Behavior Disorder; Sympathetic Fibers, Postganglionic | 2008 |
Low myocardial MIBG uptake in multiple system atrophy with incidental Lewy body pathology: an autopsy case report.
Topics: 3-Iodobenzylguanidine; Aged; Antiparkinson Agents; Fatal Outcome; Humans; Levodopa; Lewy Body Disease; Male; Multiple System Atrophy; Myocardium; Radiopharmaceuticals | 2008 |
Value of combining activated brain FDG-PET and cardiac MIBG for the differential diagnosis of dementia: differentiation of dementia with Lewy bodies and Alzheimer disease when the diagnoses based on clinical and neuroimaging criteria are difficult.
Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart; Humans; Image Enhancement; Lewy Body Disease; Male; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
Cardiac (123)I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease.
Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Female; Humans; Lewy Body Disease; Male; Middle Aged; Myocardium; Radionuclide Imaging; Radiopharmaceuticals | 2001 |
A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Diagnosis, Differential; Female; Heart; Humans; Hypotension, Orthostatic; Lewy Body Disease; Male; Middle Aged; Myocardium; Neuropsychological Tests; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Time Factors | 2001 |